Archive for:

Gefitinib is an anticancer drug that is used in the treatment of non-small cell lung cancer (NSCLC). It is a tyrosine kinase inhibitor which acts by interfering with the action of epidermal growth factor receptor tyrosine kinase. EGFR is overexpressed in cancer cells and it promotes cell multiplication. Therefore gefitinib stops the proliferation of cancerous